Surgery for Vocal Cord Paralysis
Medialization Vs Reinnervation for Vocal Cord Paralysis
1 other identifier
interventional
300
1 country
12
Brief Summary
Unilateral vocal fold paralysis (UVFP) is caused by injury to the nerve to the affected vocal fold. The injury to the vocal fold makes the affected person's voice sound "breathy". Voice therapy is usually tried first, and, if unsuccessful, surgical treatment is considered. The standard surgical treatment is called vocal fold medialization and aims to bring the injured cord to the midline. An alternative surgical treatment, vocal fold reinnervation, aims to bring a new nerve supply to the injured vocal fold. The reinnervation operation, which has some potential advantages over the medialization operation also requires several months for final results to be gained. The goal of this multicenter, randomized clinical trial is to see which of the two surgical treatments produces a better outcome. In order to participate in this study patients with UVFP must meet all entry criteria and must be released from voice therapy by a speech-language pathologist. Information collected for the study (pre-surgery, and at 6 and 12 months after surgery) includes voice recordings, movies made of vocal fold function, airflow and pressure measurements of the voicebox, and an outcomes questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Oct 2002
Typical duration for phase_3
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2002
CompletedFirst Submitted
Initial submission to the registry
July 9, 2003
CompletedFirst Posted
Study publicly available on registry
July 10, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2005
CompletedApril 24, 2006
April 1, 2006
July 9, 2003
April 21, 2006
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- clinical diagnosis of unilateral vocal fold paralysis
- older than 18 years of age
- intact ansa cervicalis and recurrent laryngeal nerves
- life expectancy of greater than 2 years
- onset of the vocal fold paralysis within 2 years of the time of surgery
- no gelfoam injection for at least 4 months prior to initial data collection
- able to give informed consent
- willing and able to return for 6 and 12 month data collection sessions
- able and willing to perform questionnaire (by mail) 18 months after surgery
You may not qualify if:
- abnormal non-paralyzed fold
- other disorders affecting the larynx (voice box), such as multiple sclerosis, myasthenia gravis, spasmodic dysphonia, or essential voice tremor
- prior surgery to either vocal fold
- previous or planned irradiation of the voicebox
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
University of Alabama-Birmingham
Birmingham, Alabama, United States
UC-Irvine Medical Center
Irvine, California, United States
George Washington University
Washington D.C., District of Columbia, United States
University of Minnesota
Minneapolis, Minnesota, United States
Washington University
St Louis, Missouri, 63110, United States
University of Cincinnati
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
University of Utah
Salt Lake City, Utah, United States
University of Wisconsin
Madison, Wisconsin, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randal C Paniello, MD
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 9, 2003
First Posted
July 10, 2003
Study Start
October 1, 2002
Study Completion
October 1, 2005
Last Updated
April 24, 2006
Record last verified: 2006-04